You are here

Article Text

Article menu
Download PDFPDF
Miscellaneous
N-Acetylcysteine and disease progression in COPD
  1. K Satkunam
  1. Specialist Registrar, Newham University Hospital, London, UK; karnan@doctors.org.uk

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    ▴ Decramer M, Rutten-van Mölken M, Dekhuijzen PR, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet2005;365:1552–60
    OpenUrlCrossRefPubMedWeb of Science

    It is known that oxidative stress plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). In this study the anti-oxidant N-acetylcysteine (NAC) was used to assess whether this drug could …

    View Full Text